Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.05 – $0.27
15% from low
Exchange
OTC Link
OS
P/S (TTM)
11.1
AMPLIA THERAPEUTICS LTD
No one on the platform currently holds INNMF.
No tracked institution reports a position in INNMF as of their last filing.
| Execution date | Ratio |
|---|---|
| 2018-05-03 | 1-for-10reverse |
No one on the platform has traded INNMF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $0 | — | $-0.02 | $-0.02–$-0.02 | — | 1 |
| 2028 | $10M | — | $-0.01 | $-0.01–$-0.01 | — | 1 |
| 2029 | $0 | -100.0% | $-0.01 | $-0.01–$-0.01 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| +0.00% |
| $2M |
| — |
| HBPCFHelix BioPharma Corp. | $1.71 | +0.00% | $131M | — |
| OTLCOncotelic Therapeutics, Inc. | $0.03 | -6.67% | $12M | — |
Source: Financial Modeling Prep · peers by sector/industry